Coreceptor usage and biological phenotypes of HIV-1 isolates (Q34999203)

5 August 2017

1 reference

title

Coreceptor usage and biological phenotypes of HIV-1 isolates (English)

1 reference

5 August 2017

2

Lynn Morris

1 reference

5 August 2017

Tonie Cilliers

1

1 reference

5 August 2017

1 September 2002

1 reference

Clinical Chemistry and Laboratory Medicine

5 August 2017

1 reference

5 August 2017

40

1 reference

5 August 2017

9

1 reference

5 August 2017

911-917

1 reference

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

5 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Atomic structure of the ectodomain from HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

New targets for inhibitors of HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

A new classification for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Chemokines and viruses: the dearest enemies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV fusion and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

Biological phenotype of HIV-1 and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

HIV-1 infection in a man homozygous for CCR5▵32

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.160

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.160

1 reference

5 August 2017

1 reference

PubMed ID

12435108